|
|
 |
|
Viewing report
|
|
|
Ariad Pharmaceuticals Inc (01-Feb-2012)
Directors Deals Ltd, Feb 2012, Pages: 1
Jay Lamarche, (Non-Executive) of Ariad Pharmaceuticals Inc [market cap £1472million] sold 26,900 shares at 15.055USD, holding is now 507,230 shares; representing 0.322 percent of the shares on issue. Holding has decreased 5 percent, the total trade value was £258,291 and the significance rating is 54/100.
Directors Deals monitors and analyses share transactions made by directors in the shares of their own company. We monitor 18,000 companies share transactions in 46 countries worldwide (32 in Europe, 7 in Asia, 2 in North America, 2 in Oceania, 2 in the Middle East & 2 in Africa).
|
|
|
|
